Vitamine D in Post-COVID Patients (VD-PCS)

March 29, 2022 updated by: Jens Bräunlich, Klinikum Emden
In this study routineously collected vitamine D values will compared to healthy cohorts from this year and previous years.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Emden, Germany, 26721
        • Klinikum Emden

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

healthy subjects and patients with post-COVID

Description

Inclusion Criteria:

  • patients with or without post-COVID-Syndrome

Exclusion Criteria:

  • substitution of vitamine D
  • diseases influencing vitamine D level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
healthy subjects 2019
subjects with diseases not influencing vitamine D values without substitution nor post-COVID
vitamine D values
healthy subjects 2020
subjects with diseases not influencing vitamine D values without substitution nor post-COVID
vitamine D values
healthy subjects 2021
subjects with diseases not influencing vitamine D values without substitution nor post-COVID
vitamine D values
post-COVID subjects 2021
subjects with diseases not influencing vitamine D values without substitution with diagnosed post-COVID syndrome
vitamine D values

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
vitamin D values between the groups
Time Frame: 6 months
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Actual)

September 1, 2021

Study Completion (Actual)

September 1, 2021

Study Registration Dates

First Submitted

July 16, 2021

First Submitted That Met QC Criteria

July 16, 2021

First Posted (Actual)

July 20, 2021

Study Record Updates

Last Update Posted (Actual)

March 31, 2022

Last Update Submitted That Met QC Criteria

March 29, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 1 (Other Identifier: Mobile Health and Wellness Program)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post COVID

Clinical Trials on Vitamine D in blood samples

Subscribe